Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

12
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (5)

Searched Name

Evangelia Stanitsa

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Moschopoulos CD, Stanitsa E, Protopapas K, Kavatha D, Papageorgiou SG, Antoniadou A, Papadopoulos A. Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review. Life (Basel) 2024;14:508. [PMID: 38672778 PMCID: PMC11050956 DOI: 10.3390/life14040508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2024] [Revised: 04/02/2024] [Accepted: 04/13/2024] [Indexed: 04/28/2024] Open

Angelopoulou E, Kontaxopoulou D, Fragkiadaki S, Stanitsa E, Pavlou D, Papatriantafyllou J, Koros C, Dimovski V, Šemrov D, Papageorgiou SG. Perceptions of Patients, Caregivers, and Healthcare Professionals toward Telemedicine Use for Cognitive and Movement Disorders in the Aegean Islands, Greece: A Pilot Study of the SI4CARE European Project. Geriatrics (Basel) 2023;9:3. [PMID: 38247978 PMCID: PMC10801565 DOI: 10.3390/geriatrics9010003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2023] [Revised: 12/19/2023] [Accepted: 12/21/2023] [Indexed: 01/23/2024] Open

Angelopoulou E, Stanitsa E, Karpodini CC, Bougea A, Kontaxopoulou D, Fragkiadaki S, Koros C, Georgakopoulou VE, Fotakopoulos G, Koutedakis Y, Piperi C, Papageorgiou SG. Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review. Medicina (Kaunas) 2023;59:1454. [PMID: 37629744 PMCID: PMC10456434 DOI: 10.3390/medicina59081454] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 07/19/2023] [Accepted: 08/07/2023] [Indexed: 08/27/2023]

Affiliation(s)

Efthalia Angelopoulou 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.) Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece;
Evangelia Stanitsa 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.)
Claire Chrysanthi Karpodini Sport and Physical Activity Research Centre, Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton WV1 1LY, UK;
Anastasia Bougea 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.)
Dionysia Kontaxopoulou 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.)
Stella Fragkiadaki 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.)
Christos Koros 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.)
Vasiliki Epameinondas Georgakopoulou Department of Infectious Diseases-COVID-19 Unit, Laiko General Hospital, 11527 Athens, Greece;
George Fotakopoulos Department of Neurosurgery, General University Hospital of Larissa, 41221 Larissa, Greece;
Yiannis Koutedakis Functional Architecture of Mammals in Their Environment Laboratory, Department of Physical Education and Sport Science, University of Thessaly, 38221 Volos, Greece;
Christina Piperi Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece;
Sokratis G. Papageorgiou 1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, 11528 Athens, Greece; (E.A.); (E.S.); (A.B.); (D.K.); (S.F.); (C.K.)

Collapse

Koros C, Simitsi AM, Bougea A, Papagiannakis N, Antonelou R, Pachi I, Angelopoulou E, Prentakis A, Zachou A, Chrysovitsanou C, Beratis I, Fragkiadaki S, Kontaxopoulou D, Eftymiopoulou E, Stanitsa E, Potagas C, Papageorgiou SG, Karavasilis E, Velonakis G, Prassopoulos V, Geronicola-Trapali X, Stefanis L. Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report. Medicina (Kaunas) 2023;59:1360. [PMID: 37629650 PMCID: PMC10456316 DOI: 10.3390/medicina59081360] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/28/2023] [Revised: 07/22/2023] [Accepted: 07/24/2023] [Indexed: 08/27/2023]

Abstract

Introduction: Previous epidemiological evidence has established the co-occurrence of malignant melanoma (MM) and Parkinson's disease (PD). Shared molecular mechanisms have been proposed to be implicated in this relationship. The aim of the present study was to assess the prevalence of MM in patients with sporadic and genetic types of PD, as well as in asymptomatic carriers of PD-related genes. Methods: Data regarding past medical history and concomitant disease of 1416 patients with PD (including 20 participants with prodromal disease who phenoconverted to PD), 275 healthy controls (HCs) and 670 asymptomatic carriers of PD-related genes were obtained from the database of the Parkinson's Progression Markers Initiative (PPMI). Focus was placed on information about a medical record of MM. We also retrieved data regarding the genetic status of selected PPMI participants with a positive MM history. Results: In total, 46 patients with PD reported a positive MM history. Concerning the genetic forms of PD, nine of these PD patients (2.47%) carried a Leucine Rich Repeat Kinase 2 (LRRK2) gene mutation (mainly the G2019S), while eight (4.49%) harbored a Glucocerebrosidase (GBA) gene mutation (mainly the N370S). No alpha-synuclein (SNCA) gene mutation was identified in patients with an MM history. The remaining 29 PD patients (3.5%) were genetically undetermined. In total, 18 asymptomatic carriers of PD-related genes had a positive medical history for MM: among them, 10 carried an LRRK2 gene mutation (2.69%) and 10 a GBA gene mutation (3.51%) (2 were dual carriers). MM history was identified for seven HCs (2.5%). Conclusions: We replicated the previously reported association between genetically undetermined PD (GU-PD) and MM. A correlation of LRRK2 mutations with the development of MM could not be verified in either symptomatic PD patients or asymptomatic carriers, implicating distinct pathogenetic mechanisms as compared to GU-PD. Importantly, despite the limited literature evidence on Gaucher disease, this study highlights for the first time the relatively high prevalence of MM among asymptomatic and symptomatic PD GBA mutation carriers, with potential clinical implications.

Collapse

Affiliation(s)

Christos Koros 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Athina-Maria Simitsi 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Anastasia Bougea 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Nikolaos Papagiannakis 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Roubina Antonelou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Ioanna Pachi 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Efthalia Angelopoulou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Andreas Prentakis Nuclear Medicine Unit, Attikon Hospital, 12462 Athens, Greece; (A.P.); (X.G.-T.)
Athena Zachou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Chrysa Chrysovitsanou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Ion Beratis 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Stella Fragkiadaki 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Dionysia Kontaxopoulou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Efthymia Eftymiopoulou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Evangelia Stanitsa 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Constantin Potagas 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Sokratis G. Papageorgiou 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)
Efstratios Karavasilis Research Unit of Radiology, 2nd Department of Radiology, Medical School, National and Kapodistrian University of Athens, “Attikon” University General Hospital, 11528 Athens, Greece; (E.K.); (G.V.)
Georgios Velonakis Research Unit of Radiology, 2nd Department of Radiology, Medical School, National and Kapodistrian University of Athens, “Attikon” University General Hospital, 11528 Athens, Greece; (E.K.); (G.V.)
Vasilios Prassopoulos Nuclear Medicine Unit, IASO Hospital, 15123 Athens, Greece;
Xenia Geronicola-Trapali Nuclear Medicine Unit, Attikon Hospital, 12462 Athens, Greece; (A.P.); (X.G.-T.)
Leonidas Stefanis 1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece; (A.-M.S.); (A.B.); (N.P.); (R.A.); (I.P.); (E.A.); (A.Z.); (C.C.); (I.B.); (S.F.); (D.K.); (E.E.); (E.S.); (C.P.); (S.G.P.); (L.S.)

Collapse

Liozidou A, Traikapi A, Stanitsa E, Kontaxopoulou D, Fragkiadaki S, Beratis I, Nunez-Fernandez S, Rivera D, Kingsley K, Arango-Lasprilla JC. Neuropsychology in Greece: Results from a survey of practicing professionals. Appl Neuropsychol Adult 2023;30:340-351. [PMID: 34340605 DOI: 10.1080/23279095.2021.1944145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Affiliation(s)

Athanasia Liozidou Laboratory of Cognitive Neuroscience and Clinical Neuropsychology, Psychology Department, The Scientific College of Greece, Athens, Greece Neuropsychological Laboratory, 1st Neurology Department, National and Kapodistrian University of Athens, Athens, Greece Neurology Department, Henry Dunant Hospital Center, Athens, Greece
Artemis Traikapi Department of Rehabilitation Sciences, Faculty of Health Sciences, Cyprus University of Technology, Limassol, Cyprus
Evangelia Stanitsa Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, 1st Department of Neurology, Eginition University Hospital, Athens, Greece
Dionysia Kontaxopoulou Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, 1st Department of Neurology, Eginition University Hospital, Athens, Greece Department of Early Childhood Education and Care, University of West Attica, Egaleo, Greece
Stella Fragkiadaki Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, 1st Department of Neurology, Eginition University Hospital, Athens, Greece
Ion Beratis Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, 1st Department of Neurology, Eginition University Hospital, Athens, Greece Psychology Department, The American College of Greece, Athens, Greece
Silvia Nunez-Fernandez BioCruces Bizkaia Health Research Institute, Barakaldo, Spain
Diego Rivera Departamento de Ciencias de la Salud, Universidad Pública de Navarra, Pamplona, Spain
Kristine Kingsley Institute of Cognitive and Emotional Wellness, New York, NY, USA Ferkauf Graduate School of Psychology, Yeshiva University, New York, NY, USA
Juan Carlos Arango-Lasprilla BioCruces Bizkaia Health Research Institute, Barakaldo, Spain IKERBASQUE, Basque Foundation for Science, Bilbao, Spain Department of Cell Biology and Histology, University of the Basque Country (UPV/EHU), Leioa, Spain

Collapse

Fragkiadaki S, Kontaxopoulou D, Stanitsa E, Angelopoulou E, Pavlou D, Šemrov D, Colnar S, Lustrek M, Blažica B, Vučica I, Matković R, Vukojevic K, Jelicic A, Guzzi PH, Martinović V, Medina AP, Piccoli G, Menon M, Kozetinac S, Miljković M, Kiskini C, Kokorotsikos T, Zilidou V, Radević I, Papatriantafyllou J, Thireos E, Tsouros A, Dimovski V, Papageorgiou SG. How Well Did the Healthcare System Respond to the Healthcare Needs of Older People with and without Dementia during the COVID-19 Pandemic? The Perception of Healthcare Providers and Older People from the SI4CARE Project in the ADRION Region. Geriatrics (Basel) 2023;8:geriatrics8010021. [PMID: 36826363 PMCID: PMC9957093 DOI: 10.3390/geriatrics8010021] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 01/23/2023] [Accepted: 01/28/2023] [Indexed: 02/05/2023] Open

Affiliation(s)

Stella Fragkiadaki 1st Department of Neurology, Aiginition University Hospital, Vasilissis Sofias Street 72-74, 11528 Athens, Greece
Dionysia Kontaxopoulou 1st Department of Neurology, Aiginition University Hospital, Vasilissis Sofias Street 72-74, 11528 Athens, Greece
Evangelia Stanitsa 1st Department of Neurology, Aiginition University Hospital, Vasilissis Sofias Street 72-74, 11528 Athens, Greece
Efthalia Angelopoulou 1st Department of Neurology, Aiginition University Hospital, Vasilissis Sofias Street 72-74, 11528 Athens, Greece
Dimosthenis Pavlou School of Topography and Geoinformatics, University of West Attica, Ag. Spyridonos Str., 12243 Aigalew, Greece
Darja Šemrov Faculty of Civic and Geodetic Engineering, University of Ljubljana Jamova cesta 2, 1000 Ljubljana, Slovenia
Simon Colnar School of Economics and Business, University of Ljubljana Kardeljeva ploščad 17, 1000 Ljubljana, Slovenia
Mitja Lustrek Department of Intelligent Systems, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia
Bojan Blažica Computer Systems Department, Jožef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia
Inga Vučica Department of Gerontology, Teaching Institute for Public Health of Split and Dalmatian County, Vukovarska 46, 21000 Split, Croatia
Roberta Matković Department for Research Data Collecting and Analysis, Teaching Institute for Public Health of Split and Dalmatian County, Vukovarska 46, 21000 Split, Croatia
Katarina Vukojevic Department of Anatomy, Histology and Embryology, University of Split School of Medicine, Šoltanska ul. 2, 21000 Split, Croatia
Ana Jelicic Department of Anatomy, Histology and Embryology, University of Split School of Medicine, Šoltanska ul. 2, 21000 Split, Croatia
Pietro Hiram Guzzi Municipality of Miglierina, Street B. Telesio 88040, Italy and University of Catanzaro, viale Europa, 88100 Catanzaro, Italy
Vlatka Martinović Faculty of Medicine, University Hospital Mostar, 88000 Mostar, Bosnia and Herzegovina
Amina Pekmez Medina Health Insurance and Reinsurance Fund of Federation of Bosnia and Herzegovina, Trg Heroja 14, 71000 Sarajevo, Bosnia and Herzegovina
Guido Piccoli ALOT, SI4CARE-TEAM Street Cipro, 16, 25124 Brescia, Italy
Margherita Menon ALOT, SI4CARE-TEAM Street Cipro, 16, 25124 Brescia, Italy
Srdjan Kozetinac Special Hospital Merkur, Cara Dusana 3, 36210 Vrnjaka Banja, Serbia
Miodrag Miljković Special Hospital Merkur, Cara Dusana 3, 36210 Vrnjaka Banja, Serbia
Chrysanthi Kiskini Department of European Union, Projects of Regional Development Fund of Central Macedonia, Vas. Olgas 198, 54 655, Thessaloniki, Greece
Themis Kokorotsikos Department of European Union, Projects of Regional Development Fund of Central Macedonia, Vas. Olgas 198, 54 655, Thessaloniki, Greece
Vasiliki Zilidou Lab of Medical Physics & Digital Innovation, and Thessaloniki Active & Healthy Ageing Living Lab, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
Ivan Radević Faculty of Economics, University of Montenegro, 37 Bulevar Jovana Tomaševića, 81000 Podgorica, Montenegro
John Papatriantafyllou 1st Department of Neurology, Aiginition University Hospital, Vasilissis Sofias Street 72-74, 11528 Athens, Greece
Eleftherios Thireos National Health System, Athens Medical Society, Meandrou 23, 115 28 Athens, Greece
Agis Tsouros Department of Global Health, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
Vlado Dimovski School of Economics and Business, University of Ljubljana Kardeljeva ploščad 17, 1000 Ljubljana, Slovenia
Sokratis G. Papageorgiou 1st Department of Neurology, Aiginition University Hospital, Vasilissis Sofias Street 72-74, 11528 Athens, Greece Correspondence:

Collapse

Koros C, Simitsi AM, Papagiannakis N, Bougea A, Prentakis A, Papadimitriou D, Pachi I, Beratis I, Stanitsa E, Angelopoulou E, Antonelou R, Bregianni M, Lourentzos K, Papageorgiou SG, Bonakis A, Trapali XG, Stamelou M, Stefanis L. Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study. J Parkinsons Dis 2023;13:811-818. [PMID: 37424476 PMCID: PMC10473106 DOI: 10.3233/jpd-230007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/01/2023] [Indexed: 07/11/2023]

Affiliation(s)

Christos Koros 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Athina-Maria Simitsi 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Nikolaos Papagiannakis 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Anastasia Bougea 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Andreas Prentakis 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece Nuclear Medicine Unit, Attikon Hospital, Athens, Greece
Dimitra Papadimitriou Neurology Clinic, Henry Dunan Hospital, Athens, Greece
Ioanna Pachi 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Ion Beratis 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Evangelia Stanitsa 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Efthalia Angelopoulou 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Roubina Antonelou 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Marianna Bregianni 2 Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece
Konstantinos Lourentzos 2 Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece
Sokratis G. Papageorgiou 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
Anastasios Bonakis 2 Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece
Xenia Geronicola Trapali Nuclear Medicine Unit, Attikon Hospital, Athens, Greece
Maria Stamelou 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece Neurology Clinic, Philipps University, Marburg, Germany Parkinsons disease and Movement Disorders Dept., HYGEIA Hospital, Athens, Greece
Leonidas Stefanis 1 Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece

Collapse

Simitsi AM, Koros C, Stamelou M, Beratis I, Efthymiopoulou E, Papadimitriou D, Bougea A, Picillo M, Stanitsa E, Papagiannakis N, Antonelou R, Pachi I, Papageorgiou SG, Barone P, Stefanis L. Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study. Parkinsonism Relat Disord 2022;98:72-74. [PMID: 35490542 DOI: 10.1016/j.parkreldis.2022.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Revised: 03/27/2022] [Accepted: 04/03/2022] [Indexed: 10/18/2022]

Affiliation(s)

Athina Maria Simitsi 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Christos Koros 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Maria Stamelou 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece; School of Medicine, European University of Cyprus, Nicosia, Cyprus; Neurology Clinic, Philipps University, Marburg, Germany
Ion Beratis 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Efthymia Efthymiopoulou 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Dimitra Papadimitriou Neurology Clinic, Henry Dunan Hospital, Athens, Greece
Anastasia Bougea 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Marina Picillo Centre for Neurodegenerative Diseases, University of Salerno, Italy
Evangelia Stanitsa 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Nikolaos Papagiannakis 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Roubina Antonelou 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Ioanna Pachi 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Sokratis G Papageorgiou 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Paolo Barone Centre for Neurodegenerative Diseases, University of Salerno, Italy
Leonidas Stefanis 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.

Collapse

Dimitrakis E, Katsarou MS, Lagiou M, Papastefanopoulou V, Stanitsa E, Spandidos D, Tsatsakis A, Papageorgiou S, Moutsatsou P, Antoniou K, Kroupis C, Drakoulis N. Association of vitamin D receptor gene TaqI polymorphism with Alzheimer's disease in a Southeastern European Caucasian population. Exp Ther Med 2022;23:341. [PMID: 35401802 PMCID: PMC8988159 DOI: 10.3892/etm.2022.11271] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2022] [Accepted: 03/02/2022] [Indexed: 11/22/2022] Open

Abstract

The role of vitamin D in Alzheimer's Disease (AD) has been studied over the past years. The results from numerous studies have indicated that the molecular pathways involved in the development of AD are closely related to the molecular pathways of the mechanisms of action of vitamin D. However, only a limited number of studies have described the key role of vitamin D receptor (VDR) in the regulation of the functions of vitamin D and the potential effect of single nucleotide polymorphisms (SNPs) of the VDR gene. Thus, the aim of the present study was to investigate the VDR TaqI polymorphism in relation to AD in a Southeastern European Caucasian (SEC) cohort. Further, the present study aimed to compare the results obtained with those of other AD populations. For this purpose, blood samples from 90 confirmed patients with AD [median age, 74 years; median mini-mental state examination (MMSE) score of 21; median frontal assessment battery (FAB) score of 10] and 103 healthy controls (median age, 57 years) were analyzed to determine the genotypes of TaqI (rs731236) using quantitative PCR. The frequencies (%) of the TaqI TT, TC and CC genotypes in the controls/patients were 34/48.9, 47.6/41.1 and 18.4/10.0, respectively. Statistically significant differences were observed for the TaqI C allele [odds ratio (OR). 0.54; 95% confidence interval (CI), 0.30-0.96; P=0.035], the TaqI TT genotype (OR, 1.86; 95% CI, 1.04-3.32; P=0.035) and the TaqI CC genotype (OR, 0.119; 95% CI, 0.014-0.995; P=0.032,) in relation to the MMSE score <21 in the patient's group. The TaqI TT allele was found to increase the risk of developing AD by 1.86-fold in the SEC population, while the TaqI C allele may act protectively, with a 46% lower risk of developing the disease. Patients with the TaqI CC genotype were found to have an 88% less likelihood of developing severe cognitive impairment based on the MMSE score. On the whole, the present study did not confirm the results of previous studies on the VDR TaqI C allele in patients with AD.

Collapse

Stanitsa E, Economou A, Beratis I, Kontaxopoulou D, Fragkiadaki S, Papastefanopoulou V, Pavlou D, Papantoniou P, Kroupis C, Papatriantafyllou J, Stefanis L, Yannis G, Papageorgiou SG. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia. J Alzheimers Dis 2021;84:1005-1014. [PMID: 34602476 DOI: 10.3233/jad-210622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]

Abstract

BACKGROUND

The driving behavior of patients with mild Alzheimer's disease dementia (ADD) and patients with mild cognitive impairment (MCI) is frequently characterized by errors. A genetic factor affecting cognition is apolipoprotein E4 (APOE4), with carriers of APOE4 showing greater episodic memory impairment than non-carriers. However, differences in the driving performance of the two groups have not been investigated.

OBJECTIVE

To compare driving performance in APOE4 carriers and matched non-carriers.

METHODS

Fourteen APOE4 carriers and 14 non-carriers with amnestic MCI or mild ADD underwent detailed medical and neuropsychological assessment and participated in a driving simulation experiment, involving driving in moderate and high traffic volume in a rural environment. Driving measures were speed, lateral position, headway distance and their SDs, and reaction time. APOE was genotyped through plasma samples.

RESULTS

Mixed two-way ANOVAs examining traffic volume and APOE4 status showed a significant effect of traffic volume on all driving variables, but a significant effect of APOE4 on speed variability only. APOE4 carriers were less variable in their speed than non-carriers; this remained significant after a Bonferroni correction. To further examine variability in the driving performance, coefficients of variation (COV) were computed. Larger headway distance COV and smaller lateral position COV were observed in high compared to moderate traffic. APOE4 carriers had smaller speed COV compared to non-carriers.

CONCLUSION

The lower speed variability of APOE4 carriers in the absence of neuropsychological test differences indicates reduced speed adaptations, possibly as a compensatory strategy. Simulated driving may be a sensitive method for detecting performance differences in the absence of cognitive differences.

Collapse

Affiliation(s)

Evangelia Stanitsa 1st Department of Neurology, Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, Eginition University Hospital, Athens, Greece
Alexandra Economou Department of Psychology, National and Kapodistrian University of Athens, Athens, Greece
Ion Beratis 1st Department of Neurology, Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, Eginition University Hospital, Athens, Greece
Dionysia Kontaxopoulou 1st Department of Neurology, Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, Eginition University Hospital, Athens, Greece
Stella Fragkiadaki 1st Department of Neurology, Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, Eginition University Hospital, Athens, Greece
Vicky Papastefanopoulou Department of Clinical Biochemistry, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
Dimosthenis Pavlou Department of Transportation Planning and Engineering, School of Civil Engineering, National Technical University of Athens, Athens, Greece
Panagiotis Papantoniou Department of Transportation Planning and Engineering, School of Civil Engineering, National Technical University of Athens, Athens, Greece
Christos Kroupis Department of Clinical Biochemistry, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
John Papatriantafyllou 1st Department of Neurology, Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, Eginition University Hospital, Athens, Greece
Leonidas Stefanis 1st Department of Neurology, Aiginiteio University Hospital, National and Kapodistrian University of Athens, Athens, Greece
George Yannis Department of Transportation Planning and Engineering, School of Civil Engineering, National Technical University of Athens, Athens, Greece
Sokratis G Papageorgiou 1st Department of Neurology, Memory, Cognitive Disorders and Rare Dementias Outpatient Unit, Eginition University Hospital, Athens, Greece

Collapse

Charoniti E, Papastefanopoulou V, Florou-Hatziyiannidou C, Koros C, Stanitsa E, Papatriantafyllou JD, Papageorgiou SG, Kroupis C. TARDBP p.I383V, a recurrent alteration in Greek FTD patients. J Neurol Sci 2021;428:117566. [PMID: 34271284 DOI: 10.1016/j.jns.2021.117566] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Revised: 06/27/2021] [Accepted: 07/01/2021] [Indexed: 10/20/2022]

Stanitsa E, Economou A, Papageorgiou SG. [P2–449]: DISQUALIFYING MONITORING IN ALZHEIMER's DISEASE AND NORMAL AGING: THE EXCLUSION LIST. Alzheimers Dement 2017. [DOI: 10.1016/j.jalz.2017.06.1105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]